NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

呼吸疾病用吸入器的全球市場

Respiratory Inhalers

出版商 Global Industry Analysts, Inc. 商品編碼 993232
出版日期 內容資訊 英文 461 Pages
商品交期: 最快1-2個工作天內
價格
呼吸疾病用吸入器的全球市場 Respiratory Inhalers
出版日期: 2021年04月01日內容資訊: 英文 461 Pages
簡介

全球呼吸疾病用吸入器的市場規模,預計在分析期間(2020年∼2027年)將以5.4%的年複合成長率增長,從2020年的306億美元,到2027年達到444億美元。

本報告所分析的市場區隔之一的手動,在分析期間中預計將以5.4%的年複合成長率增長,達到397億美元。

本報告提供全球呼吸疾病用吸入器市場的相關調查,提供市場佔有率,Covid-19的影響,趨勢和成長要素,各地區的市場分析,競爭情形,主要企業的簡介等資訊。

調查對象企業範例

  • AstraZeneca plc
  • Beximco Pharmaceuticals Ltd.
  • Boehringer Ingelheim GmbH
  • Cipla Ltd.
  • GlaxoSmithKline plc
  • Koninklijke Philips N.V.
  • Merck & Co., Inc
  • Omron Healthcare Europe B.V
  • PARI Medical Holding
  • Teva Pharmaceutical Industries Ltd.

目錄

I. 調查手法

II. 摘要整理

  • 市場概要
    • 影響者市場洞察
    • 全球市場的軌跡
    • Covid-19的影響與即將到來的全球景氣衰退
    • 競爭的市場佔有率
    • 競爭的市場佔有率方案
    • 競爭的市場佔有率:各市場區隔
  • 主要企業
  • 趨勢與推動要素
  • 全球市場預測

III. 市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 南美
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他南美國家
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東
  • 非洲

IV. 競爭

  • 企業簡介:34公司

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MCP17608

Abstract:

Global Respiratory Inhalers Market to Reach US$51 Billion by the Year 2027

Amid the COVID-19 crisis, the global market for Respiratory Inhalers estimated at US$33.9 Billion in the year 2020, is projected to reach a revised size of US$51 Billion by 2027, growing at a CAGR of 6% over the period 2020-2027.Manual, one of the segments analyzed in the report, is projected to grow at a 5.4% CAGR to reach US$45.4 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Digital segment is readjusted to a revised 13.1% CAGR for the next 7-year period. This segment currently accounts for a 6.9% share of the global Respiratory Inhalers market.

The U.S. Accounts for Over 36.1% of Global Market Size in 2020, While China is Forecast to Grow at a 8.2% CAGR for the Period of 2020-2027

The Respiratory Inhalers market in the U.S. is estimated at US$12.2 Billion in the year 2020. The country currently accounts for a 36.11% share in the global market. China, the world second largest economy, is forecast to reach an estimated market size of US$7 Billion in the year 2027 trailing a CAGR of 8.2% through 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.1% and 5.8% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.4% CAGR while Rest of European market (as defined in the study) will reach US$7 Billion by the year 2027.

Select Competitors (Total 131 Featured) -

  • AstraZeneca plc
  • Beximco Pharmaceuticals Ltd.
  • Boehringer Ingelheim GmbH
  • Cipla Ltd.
  • GlaxoSmithKline plc
  • Koninklijke Philips N.V.
  • Merck & Co., Inc
  • Omron Healthcare Europe B.V
  • PARI Medical Holding
  • Teva Pharmaceutical Industries Ltd.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Impact of Covid-19 and a Looming Global Recession
    • 2020 Marked as a Year of Disruption & Transformation
    • EXHIBIT 1: World Economic Growth Projections (Real GDP, Annual % Change) for 2019 to 2022
    • Inhalation Technology for Tackling COVID-19
    • Iconovo Joins Hands with ISR to Develop Inhaled Vaccine for COVID-19
    • Ongoing Studies ExploreUse of Inhalers-based Therapies to Treat COVID-19
    • Inhalers Lead to Marked Reduction in Onset of Severe Symptoms for Early COVID-19 Patients
    • Researchers Bet on Corticosteroid Inhalers to Treat COVID-19 Patients
    • Use of Inhalers amid COVID-19 Medical Crisis Outweigh Risks for Asthma Patients
    • COVID-19 Pandemic Pushes Patient Compliance Linked with Inhaler-based Drug Regime
    • Stockpiling Under COVID-19 Shadow Exacerbates Steroid Inhaler Supply Concerns
    • Concerns over COVID-19 Virus Transmission through Nebulizers Paves Way for Broader Acceptance of Respiratory Inhalers
    • Respiratory Inhalers: A Prelude
    • Types of Respiratory Inhalers
    • Metered-dose inhaler
    • Dry Powder Inhaler (DPI)
    • Soft Mist Inhalers (SMI)
    • Nebulizers
    • Pulmonary Drug Delivery using Inhalers Hold Critical Significance to Provide Respite to Patients
    • High Prevalence of Respiratory Diseases to Drive Growth
    • EXHIBIT 2: Prevalence Percentage of COPD, Asthma, and Allergic Rhinitis for Select Countries: 2016
    • EXHIBIT 3: Chronic Disease Management in Developed Countries (2019): Percentage Distribution of Patient Population by Chronic Disease Type in the US, Germany, and UK
    • Sustained Emphasis on Bringing Novel Pulmonary Disease Treatments Augurs Well for Market Growth
    • Dry Powder Inhalers Set to Drive Gains
    • Digital Dose Inhalers Accelerate Growth Pace
    • EXHIBIT 4: Global Cost of Respiratory Therapy by Disease (2019): Percentage Breakdown of Therapy Costs for Asthma, Chronic Obstructive Pulmonary Disease (COPD), Idiopathic Pulmonary Fibrosis, and Others
    • Recent Market Activity
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rise in Incidence of Asthma Drives Growth Prospects
    • Role of Respiratory Inhalers in Asthma
    • Asthma Rescue Inhalers Medications
    • Asthma Long-Term Medications
    • Select Asthma Stats
    • EXHIBIT 5: Asthma Prevalence in the US by Age: 2019
    • EXHIBIT 6: Asthma Prevalence in the US by Gender: 2019
    • EXHIBIT 7: Asthma Prevalence in the US by Race/Ethnicity: 2019
    • Rising Prevalence of Asthma in Children Supports Growth
    • Mounting Incidence of COPD Drives Use of Inhalers
    • COPD Stats
    • EXHIBIT 8: Global Prevalence of COPD by Age Group: Percentage of Men and Women Affected by the Condition
    • EXHIBIT 9: Reported COPD Cases in the US in Million : 2014-2018
    • Acute Respiratory Distress Syndrome: An Emerging Space for Inhalers
    • ARDS Fact Sheet
    • Rising Incidence of Cystic Fibrosis Offers Market Potential
    • EXHIBIT 10: Global Frequency of Genetic Mutations Carrying Cystic Fibrosis
    • Cystic Fibrosis Fact Sheet
    • Combination Therapies Gain Interest as Effective Treatment for Considered Influence Respiratory Inhaler Demand
    • Nebulizer Innovations Drive Opportunities
    • EXHIBIT 11: Global Nebulizer Devices Market by Type: 2020
    • Manufacturers Venture into Nebulizers Designed to Fight COVID-19
    • New Hot Melt Extrusion Method to Enhance Inhaler Technology
    • Advances in Pulmonary Drug Delivery Devices Drive Adoption
    • Select Innovations & Advancements
    • Smart Inhalers Gain Traction
    • Artificial Intelligence to Add Sophistication to Inhaler Technology
    • 3D Printing Seeks Role in Inhaler Manufacturing
    • Rise in Air Pollution Levels and Consequent Increase in Respiratory Diseases Trigger the Demand for Inhalers
    • EXHIBIT 12: Global Indoor Air Pollution Related Fatalities by Health Condition (In %) for 2020E
    • EXHIBIT 13: Air Pollution Levels Worldwide: Average PM2.5 Concentration (in µg/m³) in Select Countries for 2019
    • EXHIBIT 14: Global Carbon Dioxide (CO2) Emissions (in Billion Metric Tons): 2010-2019
    • EXHIBIT 15: Countries with Highest Carbon Emissions Worldwide: Percentage Breakdown of Carbon Emissions by Country (in %) for 2020E
    • Inhalers and Pollution: The Irony
    • Ballooning Geriatric Population to Spur Demand
    • EXHIBIT 16: Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
    • EXHIBIT 17: Global Life Expectancy at Age 60 and 80 Years: 2010-2015; 2020-2025; and 2045-2050
    • Increase in Healthcare Spending Stirs Demand
    • EXHIBIT 18: World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Current & Future Analysis for Respiratory Inhalers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 2: World Historic Review for Respiratory Inhalers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 3: World 15-Year Perspective for Respiratory Inhalers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2020 & 2027
    • TABLE 4: World Current & Future Analysis for Manual by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 5: World Historic Review for Manual by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 6: World 15-Year Perspective for Manual by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 7: World Current & Future Analysis for Digital by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 8: World Historic Review for Digital by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 9: World 15-Year Perspective for Digital by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 10: World Current & Future Analysis for Metered Dose by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 11: World Historic Review for Metered Dose by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 12: World 15-Year Perspective for Metered Dose by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 13: World Current & Future Analysis for Dry Powder by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 14: World Historic Review for Dry Powder by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 15: World 15-Year Perspective for Dry Powder by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 16: World Current & Future Analysis for Nebulizers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 17: World Historic Review for Nebulizers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 18: World 15-Year Perspective for Nebulizers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 19: World Current & Future Analysis for Asthma by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 20: World Historic Review for Asthma by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 21: World 15-Year Perspective for Asthma by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 22: World Current & Future Analysis for COPD by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 23: World Historic Review for COPD by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 24: World 15-Year Perspective for COPD by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 25: World Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 26: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 27: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

  • UNITED STATES
    • TABLE 28: USA Current & Future Analysis for Respiratory Inhalers by Technology - Manual and Digital - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 29: USA Historic Review for Respiratory Inhalers by Technology - Manual and Digital Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 30: USA 15-Year Perspective for Respiratory Inhalers by Technology - Percentage Breakdown of Value Sales for Manual and Digital for the Years 2012, 2020 & 2027
    • TABLE 31: USA Current & Future Analysis for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 32: USA Historic Review for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 33: USA 15-Year Perspective for Respiratory Inhalers by Product - Percentage Breakdown of Value Sales for Metered Dose, Dry Powder and Nebulizers for the Years 2012, 2020 & 2027
    • TABLE 34: USA Current & Future Analysis for Respiratory Inhalers by Application - Asthma, COPD and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 35: USA Historic Review for Respiratory Inhalers by Application - Asthma, COPD and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 36: USA 15-Year Perspective for Respiratory Inhalers by Application - Percentage Breakdown of Value Sales for Asthma, COPD and Other Applications for the Years 2012, 2020 & 2027
  • CANADA
    • TABLE 37: Canada Current & Future Analysis for Respiratory Inhalers by Technology - Manual and Digital - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 38: Canada Historic Review for Respiratory Inhalers by Technology - Manual and Digital Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 39: Canada 15-Year Perspective for Respiratory Inhalers by Technology - Percentage Breakdown of Value Sales for Manual and Digital for the Years 2012, 2020 & 2027
    • TABLE 40: Canada Current & Future Analysis for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 41: Canada Historic Review for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 42: Canada 15-Year Perspective for Respiratory Inhalers by Product - Percentage Breakdown of Value Sales for Metered Dose, Dry Powder and Nebulizers for the Years 2012, 2020 & 2027
    • TABLE 43: Canada Current & Future Analysis for Respiratory Inhalers by Application - Asthma, COPD and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 44: Canada Historic Review for Respiratory Inhalers by Application - Asthma, COPD and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 45: Canada 15-Year Perspective for Respiratory Inhalers by Application - Percentage Breakdown of Value Sales for Asthma, COPD and Other Applications for the Years 2012, 2020 & 2027
  • JAPAN
    • TABLE 46: Japan Current & Future Analysis for Respiratory Inhalers by Technology - Manual and Digital - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 47: Japan Historic Review for Respiratory Inhalers by Technology - Manual and Digital Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 48: Japan 15-Year Perspective for Respiratory Inhalers by Technology - Percentage Breakdown of Value Sales for Manual and Digital for the Years 2012, 2020 & 2027
    • TABLE 49: Japan Current & Future Analysis for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 50: Japan Historic Review for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 51: Japan 15-Year Perspective for Respiratory Inhalers by Product - Percentage Breakdown of Value Sales for Metered Dose, Dry Powder and Nebulizers for the Years 2012, 2020 & 2027
    • TABLE 52: Japan Current & Future Analysis for Respiratory Inhalers by Application - Asthma, COPD and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 53: Japan Historic Review for Respiratory Inhalers by Application - Asthma, COPD and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 54: Japan 15-Year Perspective for Respiratory Inhalers by Application - Percentage Breakdown of Value Sales for Asthma, COPD and Other Applications for the Years 2012, 2020 & 2027
  • CHINA
    • TABLE 55: China Current & Future Analysis for Respiratory Inhalers by Technology - Manual and Digital - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 56: China Historic Review for Respiratory Inhalers by Technology - Manual and Digital Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 57: China 15-Year Perspective for Respiratory Inhalers by Technology - Percentage Breakdown of Value Sales for Manual and Digital for the Years 2012, 2020 & 2027
    • TABLE 58: China Current & Future Analysis for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 59: China Historic Review for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 60: China 15-Year Perspective for Respiratory Inhalers by Product - Percentage Breakdown of Value Sales for Metered Dose, Dry Powder and Nebulizers for the Years 2012, 2020 & 2027
    • TABLE 61: China Current & Future Analysis for Respiratory Inhalers by Application - Asthma, COPD and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 62: China Historic Review for Respiratory Inhalers by Application - Asthma, COPD and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 63: China 15-Year Perspective for Respiratory Inhalers by Application - Percentage Breakdown of Value Sales for Asthma, COPD and Other Applications for the Years 2012, 2020 & 2027
  • EUROPE
    • TABLE 64: Europe Current & Future Analysis for Respiratory Inhalers by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 65: Europe Historic Review for Respiratory Inhalers by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 66: Europe 15-Year Perspective for Respiratory Inhalers by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2020 & 2027
    • TABLE 67: Europe Current & Future Analysis for Respiratory Inhalers by Technology - Manual and Digital - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 68: Europe Historic Review for Respiratory Inhalers by Technology - Manual and Digital Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 69: Europe 15-Year Perspective for Respiratory Inhalers by Technology - Percentage Breakdown of Value Sales for Manual and Digital for the Years 2012, 2020 & 2027
    • TABLE 70: Europe Current & Future Analysis for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 71: Europe Historic Review for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 72: Europe 15-Year Perspective for Respiratory Inhalers by Product - Percentage Breakdown of Value Sales for Metered Dose, Dry Powder and Nebulizers for the Years 2012, 2020 & 2027
    • TABLE 73: Europe Current & Future Analysis for Respiratory Inhalers by Application - Asthma, COPD and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 74: Europe Historic Review for Respiratory Inhalers by Application - Asthma, COPD and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 75: Europe 15-Year Perspective for Respiratory Inhalers by Application - Percentage Breakdown of Value Sales for Asthma, COPD and Other Applications for the Years 2012, 2020 & 2027
  • FRANCE
    • TABLE 76: France Current & Future Analysis for Respiratory Inhalers by Technology - Manual and Digital - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 77: France Historic Review for Respiratory Inhalers by Technology - Manual and Digital Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 78: France 15-Year Perspective for Respiratory Inhalers by Technology - Percentage Breakdown of Value Sales for Manual and Digital for the Years 2012, 2020 & 2027
    • TABLE 79: France Current & Future Analysis for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 80: France Historic Review for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 81: France 15-Year Perspective for Respiratory Inhalers by Product - Percentage Breakdown of Value Sales for Metered Dose, Dry Powder and Nebulizers for the Years 2012, 2020 & 2027
    • TABLE 82: France Current & Future Analysis for Respiratory Inhalers by Application - Asthma, COPD and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 83: France Historic Review for Respiratory Inhalers by Application - Asthma, COPD and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 84: France 15-Year Perspective for Respiratory Inhalers by Application - Percentage Breakdown of Value Sales for Asthma, COPD and Other Applications for the Years 2012, 2020 & 2027
  • GERMANY
    • TABLE 85: Germany Current & Future Analysis for Respiratory Inhalers by Technology - Manual and Digital - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 86: Germany Historic Review for Respiratory Inhalers by Technology - Manual and Digital Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 87: Germany 15-Year Perspective for Respiratory Inhalers by Technology - Percentage Breakdown of Value Sales for Manual and Digital for the Years 2012, 2020 & 2027
    • TABLE 88: Germany Current & Future Analysis for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 89: Germany Historic Review for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 90: Germany 15-Year Perspective for Respiratory Inhalers by Product - Percentage Breakdown of Value Sales for Metered Dose, Dry Powder and Nebulizers for the Years 2012, 2020 & 2027
    • TABLE 91: Germany Current & Future Analysis for Respiratory Inhalers by Application - Asthma, COPD and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 92: Germany Historic Review for Respiratory Inhalers by Application - Asthma, COPD and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 93: Germany 15-Year Perspective for Respiratory Inhalers by Application - Percentage Breakdown of Value Sales for Asthma, COPD and Other Applications for the Years 2012, 2020 & 2027
  • ITALY
    • TABLE 94: Italy Current & Future Analysis for Respiratory Inhalers by Technology - Manual and Digital - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 95: Italy Historic Review for Respiratory Inhalers by Technology - Manual and Digital Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 96: Italy 15-Year Perspective for Respiratory Inhalers by Technology - Percentage Breakdown of Value Sales for Manual and Digital for the Years 2012, 2020 & 2027
    • TABLE 97: Italy Current & Future Analysis for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 98: Italy Historic Review for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 99: Italy 15-Year Perspective for Respiratory Inhalers by Product - Percentage Breakdown of Value Sales for Metered Dose, Dry Powder and Nebulizers for the Years 2012, 2020 & 2027
    • TABLE 100: Italy Current & Future Analysis for Respiratory Inhalers by Application - Asthma, COPD and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 101: Italy Historic Review for Respiratory Inhalers by Application - Asthma, COPD and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 102: Italy 15-Year Perspective for Respiratory Inhalers by Application - Percentage Breakdown of Value Sales for Asthma, COPD and Other Applications for the Years 2012, 2020 & 2027
  • UNITED KINGDOM
    • TABLE 103: UK Current & Future Analysis for Respiratory Inhalers by Technology - Manual and Digital - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 104: UK Historic Review for Respiratory Inhalers by Technology - Manual and Digital Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 105: UK 15-Year Perspective for Respiratory Inhalers by Technology - Percentage Breakdown of Value Sales for Manual and Digital for the Years 2012, 2020 & 2027
    • TABLE 106: UK Current & Future Analysis for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 107: UK Historic Review for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 108: UK 15-Year Perspective for Respiratory Inhalers by Product - Percentage Breakdown of Value Sales for Metered Dose, Dry Powder and Nebulizers for the Years 2012, 2020 & 2027
    • TABLE 109: UK Current & Future Analysis for Respiratory Inhalers by Application - Asthma, COPD and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 110: UK Historic Review for Respiratory Inhalers by Application - Asthma, COPD and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 111: UK 15-Year Perspective for Respiratory Inhalers by Application - Percentage Breakdown of Value Sales for Asthma, COPD and Other Applications for the Years 2012, 2020 & 2027
  • SPAIN
    • TABLE 112: Spain Current & Future Analysis for Respiratory Inhalers by Technology - Manual and Digital - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 113: Spain Historic Review for Respiratory Inhalers by Technology - Manual and Digital Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 114: Spain 15-Year Perspective for Respiratory Inhalers by Technology - Percentage Breakdown of Value Sales for Manual and Digital for the Years 2012, 2020 & 2027
    • TABLE 115: Spain Current & Future Analysis for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 116: Spain Historic Review for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 117: Spain 15-Year Perspective for Respiratory Inhalers by Product - Percentage Breakdown of Value Sales for Metered Dose, Dry Powder and Nebulizers for the Years 2012, 2020 & 2027
    • TABLE 118: Spain Current & Future Analysis for Respiratory Inhalers by Application - Asthma, COPD and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 119: Spain Historic Review for Respiratory Inhalers by Application - Asthma, COPD and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 120: Spain 15-Year Perspective for Respiratory Inhalers by Application - Percentage Breakdown of Value Sales for Asthma, COPD and Other Applications for the Years 2012, 2020 & 2027
  • RUSSIA
    • TABLE 121: Russia Current & Future Analysis for Respiratory Inhalers by Technology - Manual and Digital - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 122: Russia Historic Review for Respiratory Inhalers by Technology - Manual and Digital Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 123: Russia 15-Year Perspective for Respiratory Inhalers by Technology - Percentage Breakdown of Value Sales for Manual and Digital for the Years 2012, 2020 & 2027
    • TABLE 124: Russia Current & Future Analysis for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 125: Russia Historic Review for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 126: Russia 15-Year Perspective for Respiratory Inhalers by Product - Percentage Breakdown of Value Sales for Metered Dose, Dry Powder and Nebulizers for the Years 2012, 2020 & 2027
    • TABLE 127: Russia Current & Future Analysis for Respiratory Inhalers by Application - Asthma, COPD and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 128: Russia Historic Review for Respiratory Inhalers by Application - Asthma, COPD and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 129: Russia 15-Year Perspective for Respiratory Inhalers by Application - Percentage Breakdown of Value Sales for Asthma, COPD and Other Applications for the Years 2012, 2020 & 2027
  • REST OF EUROPE
    • TABLE 130: Rest of Europe Current & Future Analysis for Respiratory Inhalers by Technology - Manual and Digital - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 131: Rest of Europe Historic Review for Respiratory Inhalers by Technology - Manual and Digital Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 132: Rest of Europe 15-Year Perspective for Respiratory Inhalers by Technology - Percentage Breakdown of Value Sales for Manual and Digital for the Years 2012, 2020 & 2027
    • TABLE 133: Rest of Europe Current & Future Analysis for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 134: Rest of Europe Historic Review for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 135: Rest of Europe 15-Year Perspective for Respiratory Inhalers by Product - Percentage Breakdown of Value Sales for Metered Dose, Dry Powder and Nebulizers for the Years 2012, 2020 & 2027
    • TABLE 136: Rest of Europe Current & Future Analysis for Respiratory Inhalers by Application - Asthma, COPD and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 137: Rest of Europe Historic Review for Respiratory Inhalers by Application - Asthma, COPD and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 138: Rest of Europe 15-Year Perspective for Respiratory Inhalers by Application - Percentage Breakdown of Value Sales for Asthma, COPD and Other Applications for the Years 2012, 2020 & 2027
  • ASIA-PACIFIC
    • TABLE 139: Asia-Pacific Current & Future Analysis for Respiratory Inhalers by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 140: Asia-Pacific Historic Review for Respiratory Inhalers by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 141: Asia-Pacific 15-Year Perspective for Respiratory Inhalers by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2020 & 2027
    • TABLE 142: Asia-Pacific Current & Future Analysis for Respiratory Inhalers by Technology - Manual and Digital - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 143: Asia-Pacific Historic Review for Respiratory Inhalers by Technology - Manual and Digital Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 144: Asia-Pacific 15-Year Perspective for Respiratory Inhalers by Technology - Percentage Breakdown of Value Sales for Manual and Digital for the Years 2012, 2020 & 2027
    • TABLE 145: Asia-Pacific Current & Future Analysis for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 146: Asia-Pacific Historic Review for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 147: Asia-Pacific 15-Year Perspective for Respiratory Inhalers by Product - Percentage Breakdown of Value Sales for Metered Dose, Dry Powder and Nebulizers for the Years 2012, 2020 & 2027
    • TABLE 148: Asia-Pacific Current & Future Analysis for Respiratory Inhalers by Application - Asthma, COPD and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 149: Asia-Pacific Historic Review for Respiratory Inhalers by Application - Asthma, COPD and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 150: Asia-Pacific 15-Year Perspective for Respiratory Inhalers by Application - Percentage Breakdown of Value Sales for Asthma, COPD and Other Applications for the Years 2012, 2020 & 2027
  • AUSTRALIA
    • TABLE 151: Australia Current & Future Analysis for Respiratory Inhalers by Technology - Manual and Digital - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 152: Australia Historic Review for Respiratory Inhalers by Technology - Manual and Digital Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 153: Australia 15-Year Perspective for Respiratory Inhalers by Technology - Percentage Breakdown of Value Sales for Manual and Digital for the Years 2012, 2020 & 2027
    • TABLE 154: Australia Current & Future Analysis for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 155: Australia Historic Review for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 156: Australia 15-Year Perspective for Respiratory Inhalers by Product - Percentage Breakdown of Value Sales for Metered Dose, Dry Powder and Nebulizers for the Years 2012, 2020 & 2027
    • TABLE 157: Australia Current & Future Analysis for Respiratory Inhalers by Application - Asthma, COPD and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 158: Australia Historic Review for Respiratory Inhalers by Application - Asthma, COPD and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 159: Australia 15-Year Perspective for Respiratory Inhalers by Application - Percentage Breakdown of Value Sales for Asthma, COPD and Other Applications for the Years 2012, 2020 & 2027
  • INDIA
    • TABLE 160: India Current & Future Analysis for Respiratory Inhalers by Technology - Manual and Digital - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 161: India Historic Review for Respiratory Inhalers by Technology - Manual and Digital Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 162: India 15-Year Perspective for Respiratory Inhalers by Technology - Percentage Breakdown of Value Sales for Manual and Digital for the Years 2012, 2020 & 2027
    • TABLE 163: India Current & Future Analysis for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 164: India Historic Review for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 165: India 15-Year Perspective for Respiratory Inhalers by Product - Percentage Breakdown of Value Sales for Metered Dose, Dry Powder and Nebulizers for the Years 2012, 2020 & 2027
    • TABLE 166: India Current & Future Analysis for Respiratory Inhalers by Application - Asthma, COPD and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 167: India Historic Review for Respiratory Inhalers by Application - Asthma, COPD and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 168: India 15-Year Perspective for Respiratory Inhalers by Application - Percentage Breakdown of Value Sales for Asthma, COPD and Other Applications for the Years 2012, 2020 & 2027
  • SOUTH KOREA
    • TABLE 169: South Korea Current & Future Analysis for Respiratory Inhalers by Technology - Manual and Digital - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 170: South Korea Historic Review for Respiratory Inhalers by Technology - Manual and Digital Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 171: South Korea 15-Year Perspective for Respiratory Inhalers by Technology - Percentage Breakdown of Value Sales for Manual and Digital for the Years 2012, 2020 & 2027
    • TABLE 172: South Korea Current & Future Analysis for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 173: South Korea Historic Review for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 174: South Korea 15-Year Perspective for Respiratory Inhalers by Product - Percentage Breakdown of Value Sales for Metered Dose, Dry Powder and Nebulizers for the Years 2012, 2020 & 2027
    • TABLE 175: South Korea Current & Future Analysis for Respiratory Inhalers by Application - Asthma, COPD and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 176: South Korea Historic Review for Respiratory Inhalers by Application - Asthma, COPD and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 177: South Korea 15-Year Perspective for Respiratory Inhalers by Application - Percentage Breakdown of Value Sales for Asthma, COPD and Other Applications for the Years 2012, 2020 & 2027
  • REST OF ASIA-PACIFIC
    • TABLE 178: Rest of Asia-Pacific Current & Future Analysis for Respiratory Inhalers by Technology - Manual and Digital - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 179: Rest of Asia-Pacific Historic Review for Respiratory Inhalers by Technology - Manual and Digital Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 180: Rest of Asia-Pacific 15-Year Perspective for Respiratory Inhalers by Technology - Percentage Breakdown of Value Sales for Manual and Digital for the Years 2012, 2020 & 2027
    • TABLE 181: Rest of Asia-Pacific Current & Future Analysis for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 182: Rest of Asia-Pacific Historic Review for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 183: Rest of Asia-Pacific 15-Year Perspective for Respiratory Inhalers by Product - Percentage Breakdown of Value Sales for Metered Dose, Dry Powder and Nebulizers for the Years 2012, 2020 & 2027
    • TABLE 184: Rest of Asia-Pacific Current & Future Analysis for Respiratory Inhalers by Application - Asthma, COPD and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 185: Rest of Asia-Pacific Historic Review for Respiratory Inhalers by Application - Asthma, COPD and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 186: Rest of Asia-Pacific 15-Year Perspective for Respiratory Inhalers by Application - Percentage Breakdown of Value Sales for Asthma, COPD and Other Applications for the Years 2012, 2020 & 2027
  • LATIN AMERICA
    • TABLE 187: Latin America Current & Future Analysis for Respiratory Inhalers by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 188: Latin America Historic Review for Respiratory Inhalers by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 189: Latin America 15-Year Perspective for Respiratory Inhalers by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2012, 2020 & 2027
    • TABLE 190: Latin America Current & Future Analysis for Respiratory Inhalers by Technology - Manual and Digital - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 191: Latin America Historic Review for Respiratory Inhalers by Technology - Manual and Digital Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 192: Latin America 15-Year Perspective for Respiratory Inhalers by Technology - Percentage Breakdown of Value Sales for Manual and Digital for the Years 2012, 2020 & 2027
    • TABLE 193: Latin America Current & Future Analysis for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 194: Latin America Historic Review for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 195: Latin America 15-Year Perspective for Respiratory Inhalers by Product - Percentage Breakdown of Value Sales for Metered Dose, Dry Powder and Nebulizers for the Years 2012, 2020 & 2027
    • TABLE 196: Latin America Current & Future Analysis for Respiratory Inhalers by Application - Asthma, COPD and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 197: Latin America Historic Review for Respiratory Inhalers by Application - Asthma, COPD and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 198: Latin America 15-Year Perspective for Respiratory Inhalers by Application - Percentage Breakdown of Value Sales for Asthma, COPD and Other Applications for the Years 2012, 2020 & 2027
  • ARGENTINA
    • TABLE 199: Argentina Current & Future Analysis for Respiratory Inhalers by Technology - Manual and Digital - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 200: Argentina Historic Review for Respiratory Inhalers by Technology - Manual and Digital Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 201: Argentina 15-Year Perspective for Respiratory Inhalers by Technology - Percentage Breakdown of Value Sales for Manual and Digital for the Years 2012, 2020 & 2027
    • TABLE 202: Argentina Current & Future Analysis for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 203: Argentina Historic Review for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 204: Argentina 15-Year Perspective for Respiratory Inhalers by Product - Percentage Breakdown of Value Sales for Metered Dose, Dry Powder and Nebulizers for the Years 2012, 2020 & 2027
    • TABLE 205: Argentina Current & Future Analysis for Respiratory Inhalers by Application - Asthma, COPD and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 206: Argentina Historic Review for Respiratory Inhalers by Application - Asthma, COPD and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 207: Argentina 15-Year Perspective for Respiratory Inhalers by Application - Percentage Breakdown of Value Sales for Asthma, COPD and Other Applications for the Years 2012, 2020 & 2027
  • BRAZIL
    • TABLE 208: Brazil Current & Future Analysis for Respiratory Inhalers by Technology - Manual and Digital - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 209: Brazil Historic Review for Respiratory Inhalers by Technology - Manual and Digital Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 210: Brazil 15-Year Perspective for Respiratory Inhalers by Technology - Percentage Breakdown of Value Sales for Manual and Digital for the Years 2012, 2020 & 2027
    • TABLE 211: Brazil Current & Future Analysis for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 212: Brazil Historic Review for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 213: Brazil 15-Year Perspective for Respiratory Inhalers by Product - Percentage Breakdown of Value Sales for Metered Dose, Dry Powder and Nebulizers for the Years 2012, 2020 & 2027
    • TABLE 214: Brazil Current & Future Analysis for Respiratory Inhalers by Application - Asthma, COPD and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 215: Brazil Historic Review for Respiratory Inhalers by Application - Asthma, COPD and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 216: Brazil 15-Year Perspective for Respiratory Inhalers by Application - Percentage Breakdown of Value Sales for Asthma, COPD and Other Applications for the Years 2012, 2020 & 2027
  • MEXICO
    • TABLE 217: Mexico Current & Future Analysis for Respiratory Inhalers by Technology - Manual and Digital - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 218: Mexico Historic Review for Respiratory Inhalers by Technology - Manual and Digital Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 219: Mexico 15-Year Perspective for Respiratory Inhalers by Technology - Percentage Breakdown of Value Sales for Manual and Digital for the Years 2012, 2020 & 2027
    • TABLE 220: Mexico Current & Future Analysis for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 221: Mexico Historic Review for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 222: Mexico 15-Year Perspective for Respiratory Inhalers by Product - Percentage Breakdown of Value Sales for Metered Dose, Dry Powder and Nebulizers for the Years 2012, 2020 & 2027
    • TABLE 223: Mexico Current & Future Analysis for Respiratory Inhalers by Application - Asthma, COPD and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 224: Mexico Historic Review for Respiratory Inhalers by Application - Asthma, COPD and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 225: Mexico 15-Year Perspective for Respiratory Inhalers by Application - Percentage Breakdown of Value Sales for Asthma, COPD and Other Applications for the Years 2012, 2020 & 2027
  • REST OF LATIN AMERICA
    • TABLE 226: Rest of Latin America Current & Future Analysis for Respiratory Inhalers by Technology - Manual and Digital - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 227: Rest of Latin America Historic Review for Respiratory Inhalers by Technology - Manual and Digital Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 228: Rest of Latin America 15-Year Perspective for Respiratory Inhalers by Technology - Percentage Breakdown of Value Sales for Manual and Digital for the Years 2012, 2020 & 2027
    • TABLE 229: Rest of Latin America Current & Future Analysis for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 230: Rest of Latin America Historic Review for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 231: Rest of Latin America 15-Year Perspective for Respiratory Inhalers by Product - Percentage Breakdown of Value Sales for Metered Dose, Dry Powder and Nebulizers for the Years 2012, 2020 & 2027
    • TABLE 232: Rest of Latin America Current & Future Analysis for Respiratory Inhalers by Application - Asthma, COPD and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 233: Rest of Latin America Historic Review for Respiratory Inhalers by Application - Asthma, COPD and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 234: Rest of Latin America 15-Year Perspective for Respiratory Inhalers by Application - Percentage Breakdown of Value Sales for Asthma, COPD and Other Applications for the Years 2012, 2020 & 2027
  • MIDDLE EAST
    • TABLE 235: Middle East Current & Future Analysis for Respiratory Inhalers by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 236: Middle East Historic Review for Respiratory Inhalers by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 237: Middle East 15-Year Perspective for Respiratory Inhalers by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2012, 2020 & 2027
    • TABLE 238: Middle East Current & Future Analysis for Respiratory Inhalers by Technology - Manual and Digital - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 239: Middle East Historic Review for Respiratory Inhalers by Technology - Manual and Digital Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 240: Middle East 15-Year Perspective for Respiratory Inhalers by Technology - Percentage Breakdown of Value Sales for Manual and Digital for the Years 2012, 2020 & 2027
    • TABLE 241: Middle East Current & Future Analysis for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 242: Middle East Historic Review for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 243: Middle East 15-Year Perspective for Respiratory Inhalers by Product - Percentage Breakdown of Value Sales for Metered Dose, Dry Powder and Nebulizers for the Years 2012, 2020 & 2027
    • TABLE 244: Middle East Current & Future Analysis for Respiratory Inhalers by Application - Asthma, COPD and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 245: Middle East Historic Review for Respiratory Inhalers by Application - Asthma, COPD and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 246: Middle East 15-Year Perspective for Respiratory Inhalers by Application - Percentage Breakdown of Value Sales for Asthma, COPD and Other Applications for the Years 2012, 2020 & 2027
  • IRAN
    • TABLE 247: Iran Current & Future Analysis for Respiratory Inhalers by Technology - Manual and Digital - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 248: Iran Historic Review for Respiratory Inhalers by Technology - Manual and Digital Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 249: Iran 15-Year Perspective for Respiratory Inhalers by Technology - Percentage Breakdown of Value Sales for Manual and Digital for the Years 2012, 2020 & 2027
    • TABLE 250: Iran Current & Future Analysis for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 251: Iran Historic Review for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 252: Iran 15-Year Perspective for Respiratory Inhalers by Product - Percentage Breakdown of Value Sales for Metered Dose, Dry Powder and Nebulizers for the Years 2012, 2020 & 2027
    • TABLE 253: Iran Current & Future Analysis for Respiratory Inhalers by Application - Asthma, COPD and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 254: Iran Historic Review for Respiratory Inhalers by Application - Asthma, COPD and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 255: Iran 15-Year Perspective for Respiratory Inhalers by Application - Percentage Breakdown of Value Sales for Asthma, COPD and Other Applications for the Years 2012, 2020 & 2027
  • ISRAEL
    • TABLE 256: Israel Current & Future Analysis for Respiratory Inhalers by Technology - Manual and Digital - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 257: Israel Historic Review for Respiratory Inhalers by Technology - Manual and Digital Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 258: Israel 15-Year Perspective for Respiratory Inhalers by Technology - Percentage Breakdown of Value Sales for Manual and Digital for the Years 2012, 2020 & 2027
    • TABLE 259: Israel Current & Future Analysis for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 260: Israel Historic Review for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 261: Israel 15-Year Perspective for Respiratory Inhalers by Product - Percentage Breakdown of Value Sales for Metered Dose, Dry Powder and Nebulizers for the Years 2012, 2020 & 2027
    • TABLE 262: Israel Current & Future Analysis for Respiratory Inhalers by Application - Asthma, COPD and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 263: Israel Historic Review for Respiratory Inhalers by Application - Asthma, COPD and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 264: Israel 15-Year Perspective for Respiratory Inhalers by Application - Percentage Breakdown of Value Sales for Asthma, COPD and Other Applications for the Years 2012, 2020 & 2027
  • SAUDI ARABIA
    • TABLE 265: Saudi Arabia Current & Future Analysis for Respiratory Inhalers by Technology - Manual and Digital - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 266: Saudi Arabia Historic Review for Respiratory Inhalers by Technology - Manual and Digital Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 267: Saudi Arabia 15-Year Perspective for Respiratory Inhalers by Technology - Percentage Breakdown of Value Sales for Manual and Digital for the Years 2012, 2020 & 2027
    • TABLE 268: Saudi Arabia Current & Future Analysis for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 269: Saudi Arabia Historic Review for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 270: Saudi Arabia 15-Year Perspective for Respiratory Inhalers by Product - Percentage Breakdown of Value Sales for Metered Dose, Dry Powder and Nebulizers for the Years 2012, 2020 & 2027
    • TABLE 271: Saudi Arabia Current & Future Analysis for Respiratory Inhalers by Application - Asthma, COPD and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 272: Saudi Arabia Historic Review for Respiratory Inhalers by Application - Asthma, COPD and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 273: Saudi Arabia 15-Year Perspective for Respiratory Inhalers by Application - Percentage Breakdown of Value Sales for Asthma, COPD and Other Applications for the Years 2012, 2020 & 2027
  • UNITED ARAB EMIRATES
    • TABLE 274: UAE Current & Future Analysis for Respiratory Inhalers by Technology - Manual and Digital - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 275: UAE Historic Review for Respiratory Inhalers by Technology - Manual and Digital Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 276: UAE 15-Year Perspective for Respiratory Inhalers by Technology - Percentage Breakdown of Value Sales for Manual and Digital for the Years 2012, 2020 & 2027
    • TABLE 277: UAE Current & Future Analysis for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 278: UAE Historic Review for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 279: UAE 15-Year Perspective for Respiratory Inhalers by Product - Percentage Breakdown of Value Sales for Metered Dose, Dry Powder and Nebulizers for the Years 2012, 2020 & 2027
    • TABLE 280: UAE Current & Future Analysis for Respiratory Inhalers by Application - Asthma, COPD and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 281: UAE Historic Review for Respiratory Inhalers by Application - Asthma, COPD and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 282: UAE 15-Year Perspective for Respiratory Inhalers by Application - Percentage Breakdown of Value Sales for Asthma, COPD and Other Applications for the Years 2012, 2020 & 2027
  • REST OF MIDDLE EAST
    • TABLE 283: Rest of Middle East Current & Future Analysis for Respiratory Inhalers by Technology - Manual and Digital - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 284: Rest of Middle East Historic Review for Respiratory Inhalers by Technology - Manual and Digital Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 285: Rest of Middle East 15-Year Perspective for Respiratory Inhalers by Technology - Percentage Breakdown of Value Sales for Manual and Digital for the Years 2012, 2020 & 2027
    • TABLE 286: Rest of Middle East Current & Future Analysis for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 287: Rest of Middle East Historic Review for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 288: Rest of Middle East 15-Year Perspective for Respiratory Inhalers by Product - Percentage Breakdown of Value Sales for Metered Dose, Dry Powder and Nebulizers for the Years 2012, 2020 & 2027
    • TABLE 289: Rest of Middle East Current & Future Analysis for Respiratory Inhalers by Application - Asthma, COPD and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 290: Rest of Middle East Historic Review for Respiratory Inhalers by Application - Asthma, COPD and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 291: Rest of Middle East 15-Year Perspective for Respiratory Inhalers by Application - Percentage Breakdown of Value Sales for Asthma, COPD and Other Applications for the Years 2012, 2020 & 2027
  • AFRICA
    • TABLE 292: Africa Current & Future Analysis for Respiratory Inhalers by Technology - Manual and Digital - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 293: Africa Historic Review for Respiratory Inhalers by Technology - Manual and Digital Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 294: Africa 15-Year Perspective for Respiratory Inhalers by Technology - Percentage Breakdown of Value Sales for Manual and Digital for the Years 2012, 2020 & 2027
    • TABLE 295: Africa Current & Future Analysis for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 296: Africa Historic Review for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 297: Africa 15-Year Perspective for Respiratory Inhalers by Product - Percentage Breakdown of Value Sales for Metered Dose, Dry Powder and Nebulizers for the Years 2012, 2020 & 2027
    • TABLE 298: Africa Current & Future Analysis for Respiratory Inhalers by Application - Asthma, COPD and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 299: Africa Historic Review for Respiratory Inhalers by Application - Asthma, COPD and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 300: Africa 15-Year Perspective for Respiratory Inhalers by Application - Percentage Breakdown of Value Sales for Asthma, COPD and Other Applications for the Years 2012, 2020 & 2027

IV. COMPETITION

  • Total Companies Profiled: 131